GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Akamai Technologies AKAM · USD

Information Technology · IT Services · US listing · 🇺🇸 United States

S&P 500

Compare

80.29

-3.37%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

31 analysts, 1 Nov 2026. The analysts' own views, not ours.

  • 8Strong buy
  • 13Buy
  • 9Hold
  • 1Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Nov 2026. Not our view.

Last close 80.29Average target 152.07

Low
76.00
Average
152.07
Median
165.00
High
195.00

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
Revenue$4.49bn$5.21bn$6.37bn$8.01bn$8.76bn
Revenue, highest$4.51bn$5.40bn$7.11bn$8.32bn$9.10bn
Revenue, lowest$4.45bn$4.88bn$5.33bn$7.56bn$8.26bn
Earnings per share6.676.748.5411.4113.40
Earnings per share, highest6.808.3212.3711.9914.07
Earnings per share, lowest6.395.446.1010.5712.41
Analysts191913116

Earnings against forecasts

Earnings per share by fiscal quarter

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Forecast1.571.631.791.671.581.601.541.62
Reported1.591.611.841.861.731.701.661.59
Difference+1.3%-1.4%+2.8%+11.3%+9.3%+6.2%+7.7%-1.9%

Rating changes

Latest broker notes

  • JP MorganUnderweight → Neutral
  • SusquehannaPositive
  • HSBCBuy → Hold
  • UBSNeutral
  • TD CowenHold
  • RBC CapitalSector Perform
  • Piper SandlerNeutral
  • GuggenheimBuy
  • Evercore ISI GroupOutperform
  • Morgan StanleyOverweight
  • B of A SecuritiesNeutral → Buy
  • SusquehannaPositive

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

4 / 10

Revenue growth 6.7% a year over 10 years. Return on equity 9.1%.

Model fair value

154.84

From earnings 154.84, from revenue 105.43.

Piotroski score

3 / 9

A nine-point test of financial strength, for 31 Dec 2024.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.